Inhaled Ensifentrine Improves Lung Function, Phase 3 Trial Shows |... - COPD News Today

Ensifentrine safely and effectively improved lung function and reduced the rate and risk of exacerbations in COPD patients in a trial.

Ensifentrine, Verona Pharmas experimental inhalation therapy, safely and effectively improves lung function and reduces the rate and risk of exacerbations, or episodes of disease worsening, in people… [+5892 chars]

full article...